MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2019 International Congress

    Preliminary validation of a novel, comprehensive digital biomarker smartphone application to assess motor symptoms in de-novo diagnosed Parkinson patients

    F. Lipsmeier, K. Taylor, E. Volkova-Volkmar, R. Postuma, T. Kilchenmann, D. Wolf, Y. Zhang, W. Cheng, A. Scotland, J. Schjodt-Eriksen, F. Boess, D. Ness, C. Gossens, A. Post, M. Lindemann (Basel, Switzerland)

    Objective: To determine the reliability and validity of a novel, comprehensive digital biomarker remote monitoring approach to actively and passively measure motor symptom progression in…
  • 2019 International Congress

    Use of e-PROMs in Parkinson’s disease clinics: A qualitative study of healthcare professionals perceptions

    A. Khardali, L. Hughes, E. Lane (Cardiff, United Kingdom)

    Objective: To explore the views of PD healthcare professionals on the use of e-PROMs. Background: Assessment of motor AND non-motor symptoms are critical to the…
  • 2018 International Congress

    Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial

    M. Schwarzschild, E. Macklin, R. Bakshi, S. Bhattacharyya,, R. Logan, A. Ascherio; on behalf of the Parkinson Study Group SURE-PD Investigators (Boston, MA, USA)

    Objective: To investigate whether women and men with Parkinson's disease (PD) may differ in their biochemical and clinical responses to long-term treatment with urate-elevating inosine.…
  • 2018 International Congress

    Prospective, home-based assessment of motor symptoms in Parkinson’s disease by mean of the Sleep Fit app: A potential new clinical approach

    P-L. Ratti, F. Faraci, A. Mascheroni, S. Hackethal, C. Ferlito, S. Caverzasio, E-K. Choe, Y. Luo, P-E. Nunes Ferreira, A. Puiatti, A. Kaelin-Lang (Lugano, Switzerland)

    Objective: To investigate the correspondence between subjective data on motor symptoms prospectively collected at home and retrospective, subjective data assessed by structured interview in patients…
  • 2018 International Congress

    Pediatric Tics and DCD: Motor Network Disorders?

    M. Kuiper, R. Brandsma, W. Eggink, M. Egmond, J. de Vries, P. Hoekstra, A. Dietrich, D. Sival (Groningen, Netherlands)

    Objective: To characterize and quantify pediatric tics and DCD according to specific movement disorder features. Background: Until now, it has been impossible to attribute the…
  • 2018 International Congress

    Motivators, Barriers and Clinical Correlates of Physical Activity in Parkinson Disease

    S. Mantri, S. Wood, J. Duda, J. Morley (Philadelphia, PA, USA)

    Objective: To characterize physical activity levels as well as barriers and motivators for exercise in US military Veterans with Parkinson disease (PD). Background: Physical activity…
  • 2018 International Congress

    A New Scale to Measure Impairment in Patients with Writer’s Cramp

    E. Shamim, O. Ahmad, T. Wu, P. Srivanitchapoom, P. Diomi, B. Karp, K. Alter, C. Toro, B. Hodsdon, S. Pandey, J. Park, S. Meunier, M. Hallett (Largo, MD, USA)

    Objective: To validate a new writer’s cramp impairment scale (WCIS) and compare it with an existing writer’s cramp rating scale (WCRS) Background: Writer’s cramp (WC)…
  • 2018 International Congress

    Quantification of the PD Motor Syndrome Using an Inclusive Score (PD9) Derived from Sensor Data with Deep Learning

    F. Pfister, J. Goschenhofer, T. Um, D. Pichler, K. Abedinpour, D. Kulic, B. Bischl, A. Ceballos-Baumann, U. Fietzek (Munich, Germany)

    Objective: To quantify the PD motor syndrome with increased temporal and severity granularity using non-invasive internet-of-things (IoT) devices and deep learning methods. Background: Brady-hypokinetic parkinsonistic…
  • 2018 International Congress

    Toward an automated, video-based method to measure motor severity in cervical dystonia

    D. Peterson, Z. Zhang, J. Perlmutter, G. Stebbins, C. Comella (La Jolla, CA, USA)

    Objective: The objective of this study was to compare options for machine learning-based video analysis software for measuring motor severity in cervical dystonia (CD). Background:…
  • 2018 International Congress

    Validation of the French version of the Munich Dysphagia Test-Parkinson’s disease (MDT-PD) in a multilingual population of the Luxembourg Parkinson’s Study (HELP-PD)

    G. Hipp, M. Vaillant, P. Kolber, C. Pauly, L. Pavelka, D. Reiter, R. Krüger, J. Simons (Belvaux, Luxembourg)

    Objective: To provide the psychometric validation of the French MDT-PD in the Luxembourgish multilingual population. Background: The MDT-PD, developed and validated in German [1], is…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28953 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley